Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction

Clinical and Experimental Medicine

Volumn 1, Issue 2, 2001, Pages 105-111

  Mitani, S ^a   Kamata, H ^b   Fujiwara, M ^c   Aoki, N ^d   Tango, T ^e   Fukuchi, K ^f   Oka, T ^g  

^a Okinawa Prefectural College of Nursing   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^e NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^f SHOWA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

c myc amplification; Digoxigenin labeled probe; Histological type; Lung cancer; Polymerase chain reaction

Indexed keywords

DIGOXIGENIN;

ADENOCARCINOMA; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; GENE AMPLIFICATION; GENE FREQUENCY; GENE NUMBER; HISTOLOGY; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

EID: 0034752104     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-001-8020-5     Document Type: Article

References (29)

1. L-myc cooperates with ras to transform primary rat embryo fibroblasts
2. Tumorigenic conversion of primary embryo fibroblast requires at least two cooperating oncogenes
3. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
4. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2
5. N-myc can cooperate with ras to transform normal cells in culture
6. myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens
7. p53 genetic abnormalities and myc activation in human lung carcinoma
8. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines
9. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer
10. MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer
11. Amplification and expression of protooncogenes in human small cell lung cancer cell lines
12. Amplification and expresion of the c-myc oncogene in human lung cancer cell lines
13. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics
14. myc-family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course
15. The role of myc, jun, and fos oncogenes in human lung cancer
16. New human tumor cell lines
17. Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction
18. Nucleotide sequence of the human c-myc locus: Provocative open reading frame within the first exon
19. Organization and sequence of the human alpha-lactalbumin gene
20. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase
21. Approach to stationary two-dimensional pattern: Influence of focusing time and immobiline/carrier ampholyte concentrations
22. The epidemiology of tuberculosis in San Francisco: A population-based study using conventional and molecular methods
23. Relationship between human papillomavirus and oncogenes (c-myc, N-myc) amplification in human cervical cancers
24. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung
25. c-myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression
26. Heterogeneous amplification of myc family oncogenes in small cell lung carcinoma
27. c-myc, c-erbB-2, and Ki67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma
28. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases
29. Histopathologic classification of small cell lung cancer: Changing concepts and terminology